Mobilization for liver biopsy was mobilized for today.
HIV/AIDS - CD4 200 3M ago, nadir 30 early 90s - followed by Dr [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 6164**] at [**Hospital1 778**] ([**Telephone/Fax (1) 46100**] .
- US [**11-4**]: liver heterogeneous & coarsened liver texture; no hepatic masses or ascites; enlarged spleen - EGD [**3-4**]: 2 cords of non bleeding grade I varices and 1 cord grade 2 varices lower 1/3 esophagus and GEJ.
Physical Exam: 97.6  126/60   76  RR 18 92% GEN: sleepy, arousable, remarks that he is in pain HEENT: ncat, temporal wasting CV: RRR s1, s2, no M/G/R RESP: CTA bialterally ABD: tender to palpation diffusly.
somewhat distended EXT: no edema   Pertinent Results: LABORATORY STUDIES  COMPLETE BLOOD COUNT [**2133-1-27**] 09:00AM BLOOD WBC-5.8 RBC-4.81 Hgb-14.9 Hct-44.1 MCV-92 MCH-31.0 MCHC-33.7 RDW-14.3 Plt Ct-76* [**2133-1-28**] 05:30AM BLOOD WBC-6.1 RBC-4.57* Hgb-14.5 Hct-42.5 MCV-93 MCH-31.7 MCHC-34.1 RDW-14.3 Plt Ct-81* [**2133-1-31**] 03:40AM BLOOD WBC-23.1* RBC-3.80* Hgb-11.8* Hct-35.2* MCV-93 MCH-31.2 MCHC-33.7 RDW-15.4 Plt Ct-199 [**2133-2-5**] 05:05AM BLOOD WBC-12.4* RBC-3.77* Hgb-11.7* Hct-35.7* MCV-95 MCH-31.0 MCHC-32.7 RDW-17.3* Plt Ct-128* [**2133-2-6**] 05:50AM BLOOD WBC-11.2* RBC-3.62* Hgb-11.2* Hct-34.2* MCV-95 MCH-30.9 MCHC-32.7 RDW-16.6* Plt Ct-107*  COAGULATION [**2133-1-27**] 09:00AM BLOOD PT-15.6* INR(PT)-1.4* [**2133-2-6**] 05:50AM BLOOD PT-16.8* PTT-48.8* INR(PT)-1.5*  FACTOR VIII LEVELS [**2133-1-27**] 11:10AM BLOOD FacVIII-43* [**2133-1-27**] 04:57PM BLOOD FacVIII-39* [**2133-1-28**] 04:55PM BLOOD FacVIII-61 [**2133-1-29**] 05:30AM BLOOD FacVIII-68 [**2133-1-29**] 01:00PM BLOOD FacVIII-79 [**2133-1-29**] 05:15PM BLOOD FacVIII-76 [**2133-1-30**] 12:07AM BLOOD FacVIII-77 [**2133-1-30**] 05:24PM BLOOD FacVIII-82 [**2133-1-31**] 06:25PM BLOOD FacVIII-57 [**2133-2-1**] 05:37PM BLOOD FacVIII-74  CHEMISTRY [**2133-1-28**] 05:30AM BLOOD Glucose-119* UreaN-14 Creat-0.7 Na-130* K-4.0 Cl-100 HCO3-26 AnGap-8 [**2133-2-6**] 05:50AM BLOOD Glucose-97 UreaN-22* Creat-0.7 Na-134 K-3.4 Cl-98 HCO3-29 AnGap-10 [**2133-1-28**] 05:30AM BLOOD ALT-39 AST-54* AlkPhos-131* TotBili-3.5* [**2133-2-1**] 04:52AM BLOOD ALT-129* AST-131* LD(LDH)-244 AlkPhos-150* Amylase-21 TotBili-7.4* DirBili-4.5* IndBili-2.9 [**2133-2-6**] 05:50AM BLOOD ALT-35 AST-39 AlkPhos-135* TotBili-8.9* [**2133-1-28**] 05:30AM BLOOD Albumin-2.2* Calcium-7.7* Phos-2.1* Mg-1.7 [**2133-2-6**] 05:50AM BLOOD Calcium-7.8* Phos-2.6* Mg-2.1  REPORTS AND STUDIES:  LIVER BIOPSY Liver, needle core biopsy: Foci of hepatocellular carcinoma, well-moderately differentiated.. Immunostains of the tumor  are positive for HepPar 1, unabsorbed CEA, and CAM 5.2; and negative for cytokeratins AE1:AE3, CK7 and CK20, with satisfactory controls.
CT FROM [**2133-1-29**] 1.
CXR [**2133-2-4**] Markedly reduced pleural effusion with persistent small bilateral pleural effusion.
Hilar contours, pulmonary vasculature, heart size, cardiomediastinal silhouette is within normal limits.
Brief Hospital Course: Mr [**Known lastname 35507**] was admitted for post-procedure monitoring after liver biopsy.
Stat CT showed active bleeding from a ruptured HCC in the dome of the liver.
He returned to the floor, and hematocrits remained stable, and he was discharged to outpatient follow-up.
The liver biopsy was successfully obtained via transcutaneous approach.
Pathology showed multiple foci of hepatocellular carcinoma.
He was referred to a GI oncologist to be seen after discharge (possible eligibility for Sorafenib/Nexavar treatment).
He recieved 1830 IU q8h for the first day, then q12 hours days [**2-1**] post procedure.
An emergent CT was obtained which showed ruptured HCC with active extravasation of contrast into the peritoneal cavity.
He was transferred to the intensive care unit for further observation.
MICU COURSE: The patient was admitted to the medical ICU after a CT scan performed due to abdominal pain following a transcutatneous liver biopsy shoed active bleeding from his liver.
He did not require transfusions and his hematocrit nadir was 31.
Vitamin C  Oral 12.
You have a follow-up appointment with Dr. [**Last Name (STitle) 497**]: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 8507**], MD Phone:[**Telephone/Fax (1) 2422**] Date/Time:[**2133-2-27**] 8:20  You also have the following appointments scheduled: DR. [**First Name (STitle) **] [**Doctor Last Name **] - NEBH ORTHOPEDIC PRIVATE PRACTICE Phone:[**Telephone/Fax (1) 11262**] Date/Time:[**2133-4-1**] 3:45
